İlaç Tedavisi ve Beslenmede Pediatriye Özgü Yaklaşımlar

Year 2024, Issue: 22, 395 - 411, 30.04.2024

Beyza Armağan , Elif Demirbaş , Murat Ihlamur

https://doi.org/10.38079/igusabder.1373380

Abstract

Pediatrik hastaların gereksinimleri, tedavi şekilleri, hastaneye yatış sebepleri genelde erişkinlerde farklılık göstermektedir. Bu hastalıklar, beslenme gereksinimlerinde de önemli değişikliklere yol açmaktadır. Değişen gereksinimler pediatrik hastalar için büyük önem arz etmektedir. Uygulanan tedavide kullanılan ilaçların neden olduğu beslenme problemleri ve besin-ilaç, ilaç-ilaç etkileşimlerinin de dikkate alınması gerekmektedir. Pediatrik hastalarda gereksinimlerine göre hareket etmek tedavi sürecinde kolaylık sağlayarak iyileşmeyi ve yaşam kalitesinin artmasını sağlamaktadır. Bu çalışmada, pediatrik hastaların tedavi sürecinde kullanılan ilaçların birbiriyle etkileşimleri, tükettikleri besinlerle etkileşimi ve bu süreçte oluşan beslenme problemleri üzerinde durularak konunun önemine dikkat çekmek amaçlanmıştır.

Keywords

Besin, ilaç, etkileşim, hastalık, gıda takviyesi

Pediatric-Specific Approaches In Medication Therapy and Nutrition

Abstract

The needs, treatment methods, and reasons for hospitalization of pediatric patients generally differ from those of adults. These diseases also lead to significant changes in nutritional requirements. Changing needs are of great importance to pediatric patients. Nutritional problems caused by the drugs used during the treatment and food-drug and drug-drug interactions should also be taken into consideration. Acting according to the needs of pediatric patients facilitates the treatment process and improves recovery and quality of life. In this study, the aim is to draw attention to the importance of interactions between medications used in the treatment process of pediatric patients, interactions with the foods they consume, and the nutritional problems that arise during this process.

Keywords

Food, drug, interaction, disease, food supplement.

References

• 1. Corkins MR, Griggs KC, Groh‐Wargo S, et al. Standards for nutrition support: pediatric hospitalized patients. Nutrition in Clinical Practice. 2013;28(2):263-276.
• 2. Sanghera N, Chan PY, Khaki ZF, et al. Interventions of hospital pharmacists in improving drug therapy in children. Drug Safety. 2006;1031-1047.
• 3. Allegaert K, van den Anker J. Adverse drug reactions in neonates and infants: a population-tailored approach is needed. Br J Clin Pharmacol. 2015;788–795.
• 4. Ekvall S, Ekvall VK. Pediatric nutrition in chronic diseases and developmental disorders: prevention, assessment, and treatment. Drug Therapy and Nutrition. 2005;195-207.
• 5. Kleinman RE, Baldassano RN, Caplan A, et al. Nutrition support for pediatric patients with ınflammatory bowel disease: a clinical report of the North American Society For Pediatric Gastroenterology. Hepatology and Nutrition. 2004;15-27.
• 6. Sezgin Y. Vitamin B12 yetersizliğine yaklaşım. Konuralp Medical Journal. 2019;11(3):482-488.
• 7. Olfson M, Blanco C, Liu L, Moreno C, Laje G. National trends in the outpatient treatment. Arch Gen Psychiatry. 2006;679-685.
• 8. Veiby G, Gilhus N, Engelsen B. Early child development and exposure to antiepileptic drugs prenatally and through breastfeeding. JAMA Neurology. 2013;70(11):1367-1374.
• 9. Tsukahara H, Kouki K, Todoroki Y, Ohshima Y, Hiraoka M, Shigematsu Y. Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatrics International. 2002;247–253.
• 10. Celik G, Tahiroglu A, Avci A. Çocuk ve ergenlerde atipik antipsikotik ilaçların metabolik ve endokrin yan etkileri. Psikiyatride Güncel Yaklaşımlar. 2011;3(2):232-250.
• 11. Costi S, Giani T, Orsini F, Cimaz R. Drug treatment of low bone mass and other bone conditions in pediatric patients. Pediatric Drugs. 2022;103-119.
• 12. Rodbard HW. Diabetes screening, diagnosis, and therapy in pediatric patients with type 2 diabetes. The Medscape Journal of Medicine. 2008;10(8):184.
• 13. Arpaci T, Toruner EK, Altay N. Assessment of nutritional problems in pediatric patients with cancer and the information needs of their parents: a parental perspective. Asia-Pacific Journal of Oncology Nursing. 2018;5(2):231–236.
• 14. Tripodi S, Bergami E, Panigari A. The role of nutrition in children with cancer. Tumori Journal. 2023;19-27.
• 15. Papoutsakis C, Priftis K, Drakouli M, et al. Childhood overweight/obesity and asthma: is there a link? A systematic review of recent epidemiologic evidence. Journal of the Academy of Nutrition and Dietetics. 2013;77-105.
• 16. McCloud E, Papoutsakis C. A medical nutrition therapy primer for childhood asthma: current and emerging perspectives. Journal of the American Dietetic Association. 2011;1052-1064.
• 17. Bacharier L, Boner A, Carlsen KH, Eigenmann P. Diagnosis and treatment of asthma in childhood: a PRACTALL consensus report. European Academy of Allergy and Clinical Immunology. 2007;5-34.
• 18. Hughes E. Nutritional protocol for asthma. Journal of Clinical Nutrition & Dietetics. 2017.
• 19. Cook R, Blinman T. Nutritional support of the pediatric trauma patient. Seminars in Pediatric Surgery. 2010;242-251.
• 20. Allen S, Morgan G, Jordan S, Thornton C, Storey M. Dietary supplementation with lactobacilli and bifidobacteria is well tolerated and not associated with adverse events during late pregnancy and early infancy. The Journal of Nutrition. 2010;483–488.
• 21. Leaf A, Cherian S, Subramanian S. Vitamins for preterm infants. Current Paediatrics. 2004;298-305.
• 22. Bebitoğlu BT, Oğuz E, Nuhoğlu Ç, et al. Evaluation of potential drug-drug interactions in a pediatric population. Turk Pediatri Arsivi. 2020;55(1):30–38.
• 23. Zulfa I, Yunitasari F, Dewi S. Potential drug-drug interactions analysis in children out-patients with bronchopneumonia medication prescriptions. Borneo Journal of Pharmacy. 2020;3:79-83.
• 24. Hassanzad M, Tashayoie Nejad S, Mahboobipour A, Salem F, Baniasadi S. Potential drug-drug interactions in hospitalized pediatric patients with respiratory disorders: a retrospective review of clinically important interactions. Drug Metabolism and Personalized Therapy. 2020;35.